Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of a vaccine therapy for metastatic melanoma has completed, including patients with intraocular melanoma and cutaneous melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma

Drugs mentioned

• vaccine therapy (unspecified)

Snippet

Sponsor: University of Southern California | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 2 | Status: COMPLETED